Esperion Therapeutics
ESPR
#6164
Rank
NZ$1.52 B
Marketcap
NZ$6.45
Share price
-1.58%
Change (1 day)
-1.74%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.62 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are NZ$0.62 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.60 B87.34%
2023-12-31NZ$0.32 B-16.67%
2022-12-31NZ$0.39 B-30.1%
2021-12-31NZ$0.55 B14.11%
2020-12-31NZ$0.48 B53.76%
2019-12-31NZ$0.31 B48.89%
2018-12-31NZ$0.21 B-45.33%
2017-12-31NZ$0.39 B10.51%
2016-12-31NZ$0.35 B-18.03%
2015-12-31NZ$0.43 B136.17%
2014-12-31NZ$0.18 B91.93%
2013-12-31NZ$95.27 M971.84%
2012-12-31NZ$8.88 M218.27%
2011-12-31NZ$2.79 M
2002-12-31NZ$98.22 M-47.93%
2001-12-31NZ$0.18 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$2.05 B 227.03%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$13.15 B 1,991.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$360.68 B 57,240.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$69.41 B 10,934.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$1.50 B 138.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$0.35 B-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA